{{Rsnum
|rsid=9609078
|Gene=OSBP2
|Chromosome=22
|position=30757289
|Orientation=plus
|GMAF=0.1928
|Gene_s=OSBP2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.8 | 22.0 | 76.1
| HCB | 0.0 | 11.1 | 88.9
| JPT | 0.0 | 4.5 | 95.5
| YRI | 25.7 | 50.0 | 24.3
| ASW | 16.4 | 43.6 | 40.0
| CHB | 0.0 | 11.1 | 88.9
| CHD | 0.0 | 8.5 | 91.5
| GIH | 6.2 | 27.8 | 66.0
| LWK | 25.5 | 50.9 | 23.6
| MEX | 0.0 | 0.0 | 0.0
| MKK | 14.8 | 45.8 | 39.4
| TSI | 0.0 | 33.3 | 66.7
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=T
  |Pval=4E-6
  |OR=10.89
  |ORtxt=[3.528-33.61]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}